Measuring mortality in Staphylococcus aureus bloodstream infections: are 3 months of follow-up enough?
Correspondence
First Online:
Received:
Accepted:
- 108 Downloads
- 7 Citations
Keywords
Staphylococcus Aureus Antibiotic Therapy Underlying Disease Suppression Therapy Bloodstream Infection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Notes
Conflict of interest
None.
References
- 1.Hanses F, Spaeth C, Ehrenstein BP, Linde HJ, Scholmerich J, Salzberger B. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection. 2010;39:465–70.Google Scholar
- 2.Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, et al. Epidemiologie, Verlauf und Prognose der Staphylococcus aureus Bakteriämie—Erste Ergebnisse der INSTINCT Kohorte. Dtsch Med Wochenschr. 2008;133:340–5.PubMedCrossRefGoogle Scholar
- 3.Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRefGoogle Scholar
- 4.Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333–9.CrossRefGoogle Scholar
Copyright information
© Springer-Verlag 2011